LSD Anxiety Win; Pimavanserin Schizophrenia Flop; ‘Bright Light’ for Depression?

Source link :

In a phase IIb study, a single dose of an investigational LSD-containing drug (MM120) led to significantly greater reductions in 12-week scores on the Hamilton Anxiety Rating Scale compared with placebo, according to Mind Medicine. These data and prior positive trial findings prompted the FDA to designate the drug as a breakthrough therapy for generalized […]

Author : News Health

Publish date : 2024-03-13 15:00:35

Copyright for syndicated content belongs to the linked Source.